Merck Commits $2.9 Billion to Expand Research and Manufacturing in Montgomery County, Pennsylvania

Merck has committed $2.9 billion through the end of 2030 to expand research, vaccine and medicine manufacturing operations in Montgomery County, Pennsylvania.

ADVANCE bioanalytical facility opens

Around $550 million of the total supports the new ADVANCE bioanalytical research and development facility at Merck’s West Point campus and its Spring House Innovation Park. ADVANCE is a 120,000-square-foot, robotics- and AI-enabled laboratory for analyzing clinical trial samples and is expected to employ 150 to 200 scientists.

Rob Davis, Chairman and CEO of Merck said:

“The ADVANCE facility represents the future of clinical development at Merck and underscores our continued commitment to addressing the needs of the patients we serve.”

State support

The Pennsylvania Department of Community and Economic Development proposed a $5 million Redevelopment Assistance Capital Program (RACP) grant for the initial projects.

DCED Secretary Rick Siger said:

“Merck’s continued investment in Montgomery County is a testament to Pennsylvania’s strength as a global hub for life sciences, innovation, and advanced manufacturing.”